Gilbert Wagener
Director Técnico/Científico/I+D en PHARNEXT SCA .
Cargos activos de Gilbert Wagener
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PHARNEXT SCA | Director Técnico/Científico/I+D | 15/06/2023 | - |
Historial de carrera de Gilbert Wagener
Antiguos cargos conocidos de Gilbert Wagener.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Director Técnico/Científico/I+D | - | - |
Cell2B - Advanced Therapeutics SA
 Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal. | Director Técnico/Científico/I+D | - | - |
Formación de Gilbert Wagener.
| Philipps University of Marburg | Doctorate Degree |
| University of Basel | Masters Business Admin |
| Erasmus University Rotterdam | Doctorate Degree |
Estadísticas
Internacional
| Portugal | 2 |
| Alemania | 2 |
| Suiza | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHARNEXT SCA | Health Technology |
| Empresas privadas | 2 |
|---|---|
Cell2B - Advanced Therapeutics SA
Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal. | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Gilbert Wagener
- Experiencia
